EMD-12187

Single-particle
2.9 Å
EMD-12187
3D View Gallery
Deposition: 11/01/2021
Map released: 17/02/2021
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-12187

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7bh9 summary report (pdf.gz) Map-7bh9 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain

EMD-12187

Single-particle
2.9 Å
EMD-12187
3D View Gallery
Deposition: 11/01/2021
Map released: 17/02/2021
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain
Fitted models: 7bh9

Deposition Authors: Elad N, Dym O
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradnik J , Marciano S, Shemesh M, Zoler E , Harari D, Chiaravalli J , Meyer B , Rudich Y , Li C, Marton I, Dym O, Elad N, Lewis MG , Andersen H , Gagne M, Seder RA , Douek DC, Schreiber G
(2021) Nat Microbiol , 6 , 1188 - 1198
PUBMED: 34400835
DOI: doi:10.1038/s41564-021-00954-4
ISSN: 2058-5276